ici ltici seeks gains specialty businesses imperial chemical industries plc largest chemical company united kingdom expand specialty chemicals drug businesses year 1986 results chairmanelect denys henderson we expect shift company higher valueadded businesses continue broaden base henderson told reporters informal meeting here ici today announced formation us drug company ici pharma which stuart pharmaceuticals unit double current pharmaceutical sales 11 billion dlrs 1990 henderson said our pharmaceutical business lost glaxos glaxo holdings plc not icis pharmaceutical division largest drug maker glaxo uk year us drug sales 40 pct worldwide drug sales 15 billion dlrs turn brought 27 pct total profits estimated 1990 icis pharmaceutical division account 30 pct total company profits the drug division brings highest rate return aw clements finance director ici meeting henderson us drug concern basically act sales force double exposure drugs doctors ici hire 145 salespeople october one henderson major products companys pipeline expected bring sales 200 mln dlrs annually statil treatment diabetic complications zoladex treatment advanced prostate cancer carwin treatment mild moderate congestive heart failure henderson us food drug administration approval market statil zoladex joint licensing agreements merck ltmrk expected 1989 ici expects file permission market carwin us year henderson companys 1987 results top 1986 income 888 mln dlrs 545 dlrs adr sales 15 billion dlrs declined much henderson 1987s results boosted glidden paints ici bought november 580 mln dlrs unit hanson industries inc henderson ici billion dlrs acquisitions year company made 40 acquisitions largest glidden acquisitions made year ruled acquisition pharmaceutical concern too expensive henderson role chairman effective april takes sir john harveyjones retire biggest challenge ahead lay continuing earnings momentum ici established past years restructuring selling unprofitable businesses